Literature DB >> 3804895

Development of resistance in the past decade in central Europe.

M Kresken, B Wiedemann.   

Abstract

In a multicentre study conducted by the Paul-Ehrlich-Gesellschaft we tested about 35,000 bacterial isolates from different hospitals in the Federal Republic of Germany, Berlin (West), Austria and Switzerland between 1975 and 1984. None of the bacterial species under test showed an increase in the number of resistant strains. A slight decrease in the percentage of resistant strains to some antibiotics was observed with Staphylococcus aureus; Klebsiella spp. showed a significant decrease in this respect. Because of this phenomenon and the introduction of new drugs, chemotherapy today is usually safer than ten years ago. However, in some places the amount of resistant strains was significantly different from the overall resistance. In comparison of these data with those from the U.S.A. (Atkinson & Lorian, 1984) no difference in an antibiotic-species pair exceeded 13%.

Entities:  

Mesh:

Year:  1986        PMID: 3804895     DOI: 10.1093/jac/18.supplement_c.235

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

Review 1.  The emergence of antibiotic resistance: myths and facts in clinical practice.

Authors:  J M Hamilton-Miller
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  An international study on the occurrence of multiresistant bacteria and aminoglycoside consumption patterns.

Authors:  K S Johansen; M Storgaard; N Carstensen; U Frank; F Daschner
Journal:  Infection       Date:  1988 Sep-Oct       Impact factor: 3.553

3.  A regional survey of the resistance to beta-lactam antibiotics in clinical isolates of (facultative) aerobic micro-organisms.

Authors:  E E Stobberingh; J M Philips; A W Houben; C P van Boven
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Distribution and antibiotic susceptibility of extraintestinal clinical isolates of Klebsiella, Enterobacter and Serratia species.

Authors:  P E Varaldo; F Biavasco; S Mannelli; R Pompei; A Proietti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

5.  [Resistance pattern of clinical bacterial isolates. Results of a super-regional multicenter study of the Resistance Study Committee of the Paul Ehrlich Society of Chemotherapy].

Authors:  M Kresken; B Wiedemann
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 6.  Risk factors for acquisition of multiply drug-resistant gram-negative bacteria.

Authors:  I M Gould
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

7.  Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. V.

Authors:  M Kresken; D Hafner; H Mittermayer; L Verbist; E Bergogne-Bérézin; H Giamarellou; S Esposito; B van Klingeren; F H Kayser; D S Reeves
Journal:  Infection       Date:  1994       Impact factor: 3.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.